Hims & Hers Health (NYSE:HIMS) is facing one of the most important moments in its growth story. The stock has fallen sharply, margins are under pressure, and investors are questioning whether GLP-1 demand can become a durable profit engine. But subscriber growth, positive cash flow, and international expansion still leave room for a much bigger platform if execution improves.
Stock prices used were the market prices of May 28, 2026. The video was published on June 4, 2026. On the date of publication, Rick Orford did not have (either directly or indirectly) positions in any of the securities mentioned in this video.
